Transaction · 0001127602-25-006033

Hopkinson Craig C.

Hopkinson Craig C., ER, D, CMO, reported a transaction classified as grant at Alkermes plc. involving 63991.000000 shares for an estimated $0.00. Reported holdings after the transaction were 63991.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code AER, D, CMO
ALKSAlkermes plc.
Filing timeFeb 20
Trade dateFeb 19, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ALKS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ALKS since 2025-02-20Filed 561 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
grant
Code A
Identifier
0001127602-25-006033
Employee Stock Option (Right to Buy)
Transaction date
Feb 19, 2025
Filed Feb 20, 2025, 10:13 PM · 1d delay
Shares
63.9k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
63.9k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Derivative Transaction Direct Ownership Large Holdings Increase
-6score
Filing-only score

-6

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP R&D, Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Each restricted stock unit represents a contingent right to receive one ordinary share.

  2. F2

    Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/18/2023.

  3. F3

    Shares underlying the stock option vest and become exercisable in four equal annual installments commencing on 2/19/2026.

  4. F4

    Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/19/2026.

Original filing · 0001127602-25-006033
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ALKS